• 1. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 2. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 3. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 4. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 5. Excitonic channels from bio-inspired templated supramolecular assembly of J-aggregate nanowires?
  Daniel Messmer,Stefan Salentinig,Jakob Heier Nanoscale, 2019,11, 6929-6938

Introduction to (2-Amino-5-methyl-oxazol-4-yl)-methanol (CAS No. 1240607-45-7)

(2-Amino-5-methyl-oxazol-4-yl)-methanol (CAS No. 1240607-45-7) is a versatile compound with significant potential in various fields of chemical and pharmaceutical research. This compound, characterized by its unique structure, has garnered attention for its potential applications in drug development, particularly in the areas of central nervous system (CNS) disorders and cancer therapy.

The chemical structure of (2-Amino-5-methyl-oxazol-4-yl)-methanol consists of an oxazole ring with a methyl group at the 5-position and an amino group at the 2-position, attached to a methanol moiety. This arrangement confers the molecule with specific chemical properties that make it suitable for a wide range of applications. The oxazole ring is known for its stability and ability to form hydrogen bonds, which can enhance the compound's solubility and bioavailability.

Recent studies have highlighted the pharmacological properties of (2-Amino-5-methyl-oxazol-4-yl)-methanol. One notable area of research is its potential as a neuroprotective agent. In vitro and in vivo experiments have shown that this compound can effectively protect neurons from oxidative stress and apoptosis, making it a promising candidate for the treatment of neurodegenerative diseases such as Alzheimer's and Parkinson's disease.

Moreover, (2-Amino-5-methyl-oxazol-4-yl)-methanol has been investigated for its anticancer properties. Research has demonstrated that this compound can inhibit the proliferation of various cancer cell lines, including those derived from breast, lung, and colon cancers. The mechanism of action appears to involve the modulation of key signaling pathways, such as the PI3K/AKT and MAPK pathways, which are often dysregulated in cancer cells.

In addition to its therapeutic potential, (2-Amino-5-methyl-oxazol-4-yl)-methanol has also been explored for its use as a building block in organic synthesis. Its unique functional groups make it an attractive starting material for the synthesis of more complex molecules with diverse biological activities. This versatility has led to its application in the development of new drugs and materials.

The synthesis of (2-Amino-5-methyl-oxazol-4-yl)-methanol can be achieved through several routes, including cyclization reactions and nucleophilic substitutions. One common method involves the reaction of 2-aminoethanol with a suitable methyl-substituted oxazole precursor. The choice of synthetic route depends on factors such as yield, purity, and cost-effectiveness, making it an active area of research in organic chemistry.

From a pharmaceutical development perspective, (2-Amino-5-methyl-oxazol-4-yl)-methanol has shown promise in preclinical studies. Its favorable pharmacokinetic properties, such as good oral bioavailability and low toxicity, make it a viable candidate for further clinical evaluation. Ongoing clinical trials are aimed at assessing its safety and efficacy in treating specific diseases.

Furthermore, the safety profile of (2-Amino-5-methyl-oxazol-4-yl)-methanol is an important consideration in its development as a therapeutic agent. Preclinical toxicology studies have indicated that this compound is well-tolerated at therapeutic doses, with no significant adverse effects observed in animal models. However, continued monitoring is necessary to ensure its safety in human subjects.

In conclusion, (2-Amino-5-methyl-oxazol-4-yl)-methanol (CAS No. 1240607-45-7) is a promising compound with a wide range of potential applications in chemical and pharmaceutical research. Its unique chemical structure and favorable pharmacological properties make it an attractive candidate for further investigation and development. As research continues to uncover new insights into its mechanisms of action and therapeutic potential, (2-Amino-5-methyl-oxazol-4-y-l)methanol is poised to play a significant role in advancing our understanding and treatment of various diseases.

• 45529-92-8(4,5-Dimethyloxazol-2-amine)
• 1240596-17-1(2-amino-5-methyl-1,3-oxazole-4-carboxylic acid)
• 1196156-36-1(N,4,5-trimethyl-1,3-oxazol-2-amine)
• 1780137-54-3(Methyl 2-amino-5-methyloxazole-4-carboxylate)
• 1496937-61-1(2-hydrazinyl-4,5-dimethyl-1,3-oxazole)
• 874821-67-7((5-methyl-1,3-oxazol-4-yl)methanol)
• 91114-85-1(4,5-Dimethyl-1,3-oxazol-2-amine hydrochloride)
• 2825704-25-2(4-Aminomethyl-5-methyl-oxazol-2-ylamine)
• 191399-20-9((2-amino-1,3-oxazol-4-yl)methanol)
• 3031785-31-3(2-Amino-5-methyl-oxazole-4-carboxylic acid hydrochloride)